Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sodium

S Kumar1, T Berl

  • 1Department of Medicine, University of Colorado School of Medicine, Denver 80262, USA.

Lancet (London, England)
|July 31, 1998
PubMed
Summary
This summary is machine-generated.

Serum sodium disorders are common but poorly understood. Recent advances in understanding vasopressin release, receptors, and water channels (AQP2) have improved diagnosis and led to new treatment guidelines for hyponatremia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic relevance of serum hyaluronan levels in patients with breast cancer.

International journal of cancer·1992
Same author

Acceptability trials with ready to eat foods in a rural area.

Indian pediatrics·1992
Same author

American Diabetes Association annual scientific sessions, San Antonio, 20-23 June 1992.

Diabetic medicine : a journal of the British Diabetic Association·1992
Same author

Localization of the gene for branchiootorenal syndrome to chromosome 8q.

Genomics·1992
Same author

Expression of DRG during murine embryonic development.

Biochemical and biophysical research communications·1992
Same author

DRG: a novel developmentally regulated GTP-binding protein.

Biochemical and biophysical research communications·1992
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
See all related articles

Area of Science:

  • Nephrology
  • Endocrinology
  • Internal Medicine

Background:

  • Serum sodium disorders are prevalent yet challenging clinical conditions.
  • Understanding has been limited, despite their common occurrence in patients.
  • Recent molecular and physiological discoveries offer new insights.

Purpose of the Study:

  • To summarize recent advancements in the understanding of serum sodium disorders.
  • To highlight the role of vasopressin and aquaporin-2 in water balance.
  • To discuss the development of evidence-based therapeutic guidelines for hyponatremia.

Main Methods:

  • Review of recent literature on vasopressin physiology and aquaporin-2.
  • Analysis of current controversies and consensus in hyponatremia treatment.

Related Experiment Videos

  • Synthesis of new knowledge into clinical practice recommendations.

    • Main Results:

    • Elucidation of non-osmotic vasopressin release mechanisms.
    • Cloning and characterization of vasopressin receptors and AQP2 water channels.
    • Establishment of well-accepted therapeutic guidelines for hyponatremia management.

    Conclusions:

    • Enhanced understanding of molecular mechanisms has improved the approach to serum sodium disorders.
    • New therapeutic guidelines provide a framework for managing hyponatremia.
    • Further research may continue to refine treatment strategies for electrolyte imbalances.